Skip to main content

Payers' Perspectives

Payers' Perspectives
Health Plans Must Monitor the Oncology Pipeline to Apply Appropriate Coverage Criteria, Maintain Treatment Value
James T. Kenney, RPh, MBA
Read More
Payers' Perspectives
The Challenge of Balancing Access to and Paying for New, High-Cost Cancer Therapies
James T. Kenney, RPh, MBA
Read More
Payers' Perspectives
The Potential for Improved Prescribing: A Payer Perspective
Gary M. Owens, MD
Read More
Payers' Perspectives
The Value of Pharmaceuticals and Adherence to Therapy in the Management of Hematologic Cancers
Atheer A. Kaddis, PharmD
Read More
Payers' Perspectives
Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea
Lisa A. Raedler, PhD, RPh
Read More
Payers' Perspectives
Stakeholder Integration Needed to Address a Flawed Reimbursement System
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Payers' Perspectives
Increasing Emphasis on Costs in the Management of Patients with Hematologic Cancers
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Payers' Perspectives
Cancer Care in 2013: Hope, Reality, and a Call to Action
Gary M. Owens, MD
Read More
Payers' Perspectives
New Data Presented at Highlight Challenges and Opportunities for Payers
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Payers' Perspectives
Payers Collaborate with Providers to Adopt Oncology Pathways, New Care Delivery Models
Rhonda Greenapple, MSPH
Read More
Page 1 of 2
Results 1 - 10 of 12